LNGR


Longevity Thematic ETF

Fund Summary

The Global X Longevity Thematic ETF (LNGR) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

Fund Objective

The Global X Longevity Thematic ETF (LNGR) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Global Longevity Thematic Index.

Why LNGR?

High Growth Potential

LNGR enables investors to access high growth potential through companies at the leading edge of a long-term, structural demographic trend affecting multiple sectors of the global economy.

Unconstrained Approach

LNGR's composition transcends classic sector, industry, and geographic classifications by tracking an emerging theme.

ETF Efficiency

In a single trade, LNGR delivers access to dozens of companies with high exposure to the Longevity theme.

Fund Details As of 02/23/21

Key Facts

Ticker LNGR
Inception Date 05/09/16
CUSIP 37954Y772
ISIN US37954Y7720
Bloomberg Index Ticker ILNGRNT
Primary Exchange Nasdaq
Number of Holdings 99

Stats & Fees

Net Assets $49,704,580
Net Asset Value (NAV) $28.40
Shares Outstanding 1,750,000
Total Expense Ratio 0.50%

Distributions

30-Day SEC Yield 0.48%
Distribution Frequency Semi-Annually

Fund Prices As of 02/23/21

NAV $28.40 Daily Change -$0.16 -0.58%
Market Price $28.48 Daily Change -$0.05 -0.18%
30-Day Median Bid-Ask Spread 0.24%

Performance History

As of recent
(12/31/20)
As of recent
(12/31/20)
Fund NAV Market Price Index
1 Year 19.28% 18.96% 19.60%
3 Years 13.97% 13.69% 14.21%
Since Inception 14.96% 15.39% 15.27%
1 Year 20.90% 20.87% 21.27%
3 Years 11.38% 11.49% 11.62%
Since Inception 14.75% 15.34% 15.06%
Year-to-Date 19.28% 18.96% 19.60%
1 Month 4.68% 4.19% 4.73%
3 Months 9.41% 9.06% 9.53%
Since Inception 91.01% 94.34% 93.61%
Year-to-Date 0.32% 1.00% 0.35%
1 Month 0.32% 1.00% 0.35%
3 Months 14.91% 15.38% 15.02%
Since Inception 91.63% 96.29% 94.29%

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance of the Fund, when observed, is unusual and investors should not expect such performance to be repeated.

Fund Characteristics As of 02/23/21

Return on Equity 12.80%
Weighted Avg. Market Cap 40,776 M
2020 2021
Price-to-earnings 33.23 28.23
Price-to-book value 3.78 3.45

Source: AltaVista Research, LLC

Fund Risk Stats As of 02/23/21

Versus Beta
S&P 500 0.85
MSCI EAFE 0.78
MSCI Emg. Mkts 0.64
Standard Deviation 18.30%

Source: AltaVista Research, LLC

Sector Breakdown As of 01/31/21

% of Net Assets
Health Care 93.2
Real Estate 4.9
Information Technology 0.8
Consumer Discretionary 0.4
Industrials 0.3
Other/Cash 0.4

Source: AltaVista Research, LLC

Country Breakdown As of 01/31/21

% of Net Assets
United States 59.7
Denmark 6.4
Japan 6.1
Switzerland 5.2
China 4.5
Ireland 3.1
Britain 3.1
South Korea 2.9
France 2.2
Germany 1.7
Belgium 1.4
Other/Cash 3.7

Source: AltaVista Research, LLC

Top Holdings As of 02/23/21

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
3.14 SYK STRYKER CORP 2853688 246.56 5,597 1,379,996.32
3.12 ALGN ALIGN TECHNOLOGY INC 2679204 567.81 2,417 1,372,396.77
3.04 ABBV ABBVIE INC B92SR70 106.27 12,576 1,336,451.52
2.77 EW EDWARDS LIFESCIENCES CORP 2567116 85.22 14,307 1,219,242.54
2.71 NOVOB DC NOVO NORDISK A/S-B BHC8X90 71.48 16,715 1,194,865.60
2.67 4519 JP CHUGAI PHARMA CO 6196408 49.95 23,538 1,175,612.42
2.67 MDT MEDTRONIC PLC BTN1Y11 118.00 9,948 1,173,864.00
2.59 DXCM DEXCOM INC B0796X4 406.78 2,799 1,138,577.22
2.56 068270 KS CELLTRION INC B0C5YV1 266.51 4,221 1,124,882.62
2.48 BSX BOSTON SCIENTIFIC CORP 2113434 38.75 28,118 1,089,572.50
2.46 ALC SW ALCON INC BJT1GR5 71.97 15,015 1,080,659.74
2.40 AMGN AMGEN INC 2023607 232.46 4,540 1,055,368.40
2.34 BMY BRISTOL-MYERS SQUIBB CO 2126335 60.72 16,959 1,029,750.48
2.33 ZBH ZIMMER BIOMET HO 2783815 161.87 6,340 1,026,255.80
2.24 BDX BECTON DICKINSON AND CO 2087807 247.70 3,982 986,341.40
2.16 3692 HK HANSOH PHARMACEU BJYKB72 5.37 177,300 951,246.50
2.15 4543 JP TERUMO CORP 6885074 40.70 23,276 947,293.23
2.05 REGN REGENERON PHARMACEUTICALS 2730190 468.03 1,929 902,829.87
2.02 WELL WELLTOWER INC BYVYHH4 70.60 12,599 889,489.40
1.97 BIIB BIOGEN INC 2455965 279.08 3,114 869,055.12
1.94 VRTX VERTEX PHARM 2931034 216.44 3,954 855,803.76
1.90 SGEN SEAGEN INC BLPK4D2 157.03 5,335 837,755.05
1.79 BGNE BEIGENE LTD-ADR BYYWPW6 332.47 2,368 787,288.96
1.69 GMAB DC GENMAB A/S 4595739 372.79 1,997 744,466.97
1.50 FME GR FRESENIUS MEDICA 5129074 70.55 9,327 658,016.22
1.45 EXAS EXACT SCIENCES CORP 2719951 138.71 4,596 637,511.16
1.42 VTR VENTAS INC 2927925 54.62 11,440 624,852.80
1.36 STMN SW STRAUMANN HOLDING AG-REG 7156832 1,235.08 483 596,541.35
1.32 UCB BB UCB SA 5596991 97.01 5,966 578,754.23
1.22 NVCR NOVOCURE LTD BYSS4X4 172.95 3,104 536,836.80
1.20 SN/ LN SMITH & NEPHEW PLC 0922320 19.88 26,643 529,688.26
1.19 INCY INCYTE CORP 2471950 79.02 6,650 525,483.00
1.18 SOON SW SONOVA HOLDING AG-REG 7156036 261.45 1,987 519,508.86
1.13 PODD INSULET CORP B1XGNW4 260.74 1,908 497,491.92
1.11 VAR VARIAN MEDICAL S 2927516 175.73 2,784 489,232.32
1.09 DGX QUEST DIAGNOSTICS INC 2702791 117.49 4,094 481,004.06
1.09 BIM FP BIOMERIEUX BF0LBX7 131.93 3,631 479,041.22
1.01 ABMD ABIOMED INC 2003698 321.69 1,385 445,540.65
0.88 DVA DAVITA INC 2898087 101.28 3,843 389,219.04
0.85 GN DC GN STORE NORD A/S 4501093 86.23 4,347 374,854.12
0.82 XRAY DENTSPLY SIRONA INC BYNPPC6 53.36 6,783 361,940.88
0.77 COH AU COCHLEAR LTD 6211798 171.89 1,963 337,417.31
0.73 PNTG PENNANT GROUP INC/THE BKTC976 56.61 5,688 321,997.68
0.70 DEMANT DC DEMANT A/S BZ01RF1 41.11 7,493 308,001.99
0.70 NBIX NEUROCRINE BIOSC 2623911 108.59 2,821 306,332.39
0.65 GKOS GLAUKOS CORP BYMWL19 94.07 3,024 284,467.68
0.63 AMP IM AMPLIFON SPA B14NJ71 40.47 6,898 279,140.86
0.63 AMED AMEDISYS INC 2024332 280.27 991 277,747.57
0.60 SAGE SAGE THERAPEUTICS INC BP4GNK9 80.24 3,280 263,187.20
0.60 HALO HALOZYME THERAPEUTICS INC 2975098 47.21 5,568 262,865.28
0.59 OHI OMEGA HEALTHCARE 2043274 37.63 6,858 258,066.54
0.58 ORP FP ORPEA 7339451 129.62 1,981 256,778.45
0.55 LUN DC H LUNDBECK A/S 7085259 39.58 6,131 242,693.77
0.54 IONS IONIS PHARMACEUTICALS INC BDJ0LS6 56.05 4,271 239,389.55
0.54 ACAD ACADIA PHARMACEU 2713317 49.74 4,752 236,364.48
0.52 PHM SM PHARMA MAR SA BMW2GT8 130.59 1,745 227,885.46
0.51 NVST ENVISTA HOLDINGS CORP BK63SF3 37.66 6,004 226,110.64
0.50 ENSG ENSIGN GROUP INC/THE B1YWPP8 82.47 2,655 218,957.85
0.47 EXEL EXELIXIS INC 2576941 22.22 9,358 207,887.97
0.46 MYGN MYRIAD GENETICS INC 2614153 29.03 6,905 200,452.15
0.44 LHCG LHC GROUP INC B06DT50 202.44 964 195,152.16
0.43 MOVE SW MEDACTA GROUP SA BJYLTQ0 116.40 1,630 189,730.66
0.41 IART INTEGRA LIFESCIE 2248693 69.14 2,590 179,072.60
0.39 RYM NZ RYMAN HEALTHCARE LTD 6161525 11.21 15,351 172,082.28
0.37 MMSI MERIT MEDICAL SYSTEMS INC 2580555 55.85 2,944 164,407.68
0.36 EKTAB SS ELEKTA AB-B SHS B0M42T2 14.21 11,291 160,439.05
0.36 BPMC BLUEPRINT MEDICINES CORP BWY52P3 97.45 1,607 156,602.15
0.35 BKD BROOKDALE SR B0PZN33 4.94 30,968 152,981.92
0.34 LIVN LIVANOVA PLC BYMT0J1 74.08 2,045 151,493.60
0.34 DHC DIVERSIFIED HEAL BKRN595 4.60 32,692 150,383.20
0.34 2500 HK VENUS MEDTECH -H BL6V047 10.00 15,000 150,025.15
0.34 SILK SILK ROAD MEDICAL INC BGHVXJ7 54.57 2,748 149,958.36
0.33 4544 JP H.U. GROUP HOLDINGS INC 6356611 31.30 4,702 147,168.15
0.33 RDUS RADIUS HEALTH INC BM68KK1 18.62 7,821 145,627.02
0.33 SBRA SABRA HEALTH CAR B5NLBP6 18.18 7,910 143,803.80
0.32 KORI FP KORIAN B1HKRM0 36.48 3,905 142,448.93
0.32 2186 HK LUYE PHARMA GROUP LTD BNQ4GF3 0.72 198,847 142,332.16
0.32 ATT SS ATTENDO AB BZ1N262 5.53 25,381 140,280.14
0.32 FGEN FIBROGEN INC BSDRYR8 51.27 2,730 139,967.10
0.30 AGIO AGIOS PHARMACEUTICALS INC BCBVTX1 54.17 2,413 130,712.21
0.30 ITGR INTEGER HOLDINGS CORP BD06LM7 83.96 1,545 129,718.20
0.28 NHI NATL HEALTH INVESTORS INC 2626125 67.80 1,847 125,226.60
0.28 CSH-U CN CHARTWELL RETIRE B8S8C94 8.52 14,595 124,294.10
0.28 TCMD TACTILE SYSTEMS BZB1XF2 56.80 2,162 122,801.60
0.28 CASH 0.00 177,373,198 122,764.81
0.28 AMRN AMARIN CORP PLC -ADR 2301938 7.23 16,954 122,577.42
0.28 8086 JP NIPRO CORP 6641599 13.20 9,275 122,472.53
0.28 ALKS ALKERMES PLC B3P6D26 19.65 6,221 122,242.65
0.28 LTC LTC PROPERTIES INC 2498788 41.32 2,932 121,150.24
0.26 AERI AERIE PHARMACEUTICALS INC BFRTDG1 15.66 7,355 115,179.30
0.24 NUVA NUVASIVE INC B00GJC2 57.76 1,823 105,296.48
0.23 NTUS NATUS MEDICAL INC 2771133 25.20 4,021 101,329.20
0.23 4534 JP MOCHIDA PHARMACEUTICAL CO 6598004 39.43 2,530 99,765.49
0.22 INGN INOGEN INC BJSVLL5 50.42 1,918 96,705.56
0.20 4547 JP KISSEI PHARM CO 6494061 21.28 4,133 87,956.25
0.20 8129 JP TOHO HOLDINGS CO LTD 6895556 18.73 4,613 86,410.09
0.19 NHC NATIONAL HEALTHCARE CORP 2139731 67.00 1,264 84,688.00
0.14 EPZM EPIZYME INC B9Z1QZ7 10.41 5,851 60,908.91
0.13 BLUE BLUEBIRD BIO INC BBFL7S1 25.62 2,290 58,669.80
0.13 084990 KS HELIXMITH CO LTD B0P5XC2 22.91 2,550 58,432.00
Holdings are subject to change.


Investing involves risk, including the possible loss of principal. The investable universe of companies in which LNGR may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. LNGR is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.